Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare

Community Health Systems (NYSE:CYH)

 – Shares Owned by Tipp Hill (as of March 31): 275,000

 – Value of Holding (as of March 31): $5.09 Million

The new holding of 275,000 shares of Community Health Systems amassed about 5.03% of Tipp Hill’s equity portfolio as of March 31. Shares of the operator of acute care hospitals have dropped by more than 28% this year, with a major dip coming in mid-February after the company announced its fourth quarter financial results, which saw a 1.5% decline in adjusted admissions. However, the stock is up by 18% since then, as Community Health Systems (NYSE:CYH)’s spin-off Quorum Health Corporation (NYSE:QHC) recently reported a 1.1% increase in adjusted admissions, raising hopes for better results from Community Health Systems itself. Ray Carroll‘s Breton Hill Capital was also bullish on Community Health Systems (NYSE:CYH) during the first quarter, as it raised its stake by 42% to over 48,500 shares. Moreover, Conan Laughlin’s North Tide Capital reported a more than 100% hike to its Community Health Systems stake in late March, adding further to the bullish momentum.

AbbVie Inc (NYSE:ABBV)

 – Shares Owned by Tipp Hill (as of March 31): 138,000

 – Value of Holding (as of March 31): $7.88 Million

Tipp Hill’s new stake in AbbVie represented about 7.8% of the fund’s equity portfolio on March 31. As far as AbbVie Inc (NYSE:ABBV)’s upcoming drugs are concerned, the FDA recently approved the research-based biopharmaceutical company’s New Drug Application for VIEKIRA PAK without Ribavirin, for the treatment of chronic hepatitis C virus (HCV) genotype 1b infection and compensated cirrhosis (Child-Pugh A). Although highly profitable, the competition in the hepatitis C space is stiff, with ‘ Gilead Sciences, Inc. (NASDAQ:GILD)’s Sovaldi and Harvoni treatments being the market leaders. AbbVie Inc (NYSE:ABBV)’s shares are down by 7.8% in the past 12 months, but are up by 2.8% so far this year. Woodford Investment Management, which is led by Neil Woodford, upped its stake in AbbVie during the first quarter by 26% to 11.06 million shares.

Follow Abbvie Inc. (NYSE:ABBV)
Trade (NYSE:ABBV) Now!

Tenet Healthcare Corp (NYSE:THC)

 – Shares Owned by Tipp Hill (as of March 31): 293,000

 – Value of Holding (as of March 31): $8.48 Million

Lastly in Tenet Healthcare, in which Tipp Hill initiated a 293,000-share position during the first quarter, representing an 8.37% slice of its equity portfolio on March 31. In late March, Tenet announced the completion of its sale of assets from five Atlanta-area hospitals to Wellstar Health System for $575 million in cash. The company was also excluded from the S&P 500 index recently, as Standard & Poor’s believes that it is more representative of the mid-cap space, with the company currently having a market cap of $3.23 billion. Susquehanna recently upgraded Tenet Healthcare Corp (NYSE:THC) to ‘Positive’ from ‘Neutral’. Billionaire Larry Robbins‘ Glenview Capital is another believer in Tenet Healthcare Corp (NYSE:THC)’s operations, as the fund held about 17% of the healthcare services company’s outstanding stock by the end of last year.

Follow Tenet Healthcare Corp (NYSE:THC)
Trade (NYSE:THC) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.